Trials / Completed
CompletedNCT02419521
Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Medtronic Vascular · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to assess the safety and efficacy of the Resolute Onyx Zotarolimus-Eluting Coronary Stent System for the treatment of de novo lesions in native coronary arteries with a reference vessel diameter of 2.25 mm to 4.2 mm.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Resolute Onyx Stent - 2.25 mm - 4.0 mm |
Timeline
- Start date
- 2015-07-07
- Primary completion
- 2016-07-05
- Completion
- 2018-12-03
- First posted
- 2015-04-17
- Last updated
- 2019-04-03
- Results posted
- 2017-07-28
Locations
12 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02419521. Inclusion in this directory is not an endorsement.